Gilead’s Tomas Cihlar and his team of researchers have spent decades studying HIV—and their latest innovation could be a game changer for prevention.
A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. The technology has largely been tested in cells ...
When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...
The closest-ever detailed look at a key enzyme inside the virus that causes COVID-19 could lead to more effective treatment ...
Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results